|
|
||||||||
NEUROLOGY 1986;36:562-566
© 1986 American Academy of Neurology
ARTICLES |
HS Panitch, J Gomez-Plascencia, FH Norris, K Cantell and RA Smith
Three children with stage II-III subacute sclerosing panencephalitis (SSPE) were treated with intraventricular human leukocyte interferon for 6 months. All three improved to varying degrees and for different lengths of time. Clinical remissions were associated with decreased titers of antibody to measles virus in CSF and with reduced rates of intrathecal IgG synthesis. There were no serious complications or side effects. Intraventricular interferon deserves further study as a potential therapeutic agent in SSPE.
This article has been cited by other articles:
![]() |
A. J. Cole, J. W. Henson, M. H.A. Roehrl, and M. P. Frosch Case 24-2007 -- A 20-Year-Old Pregnant Woman with Altered Mental Status N. Engl. J. Med., August 9, 2007; 357(6): 589 - 600. [Full Text] [PDF] |
||||
![]() |
R K Garg Subacute sclerosing panencephalitis Postgrad. Med. J., February 1, 2002; 78(916): 63 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Fayad, B. I. Yamout, and S. Mroueh Alpha-Interferon in the Treatment of Subacute Sclerosing Panencephalitis J Child Neurol, November 1, 1997; 12(8): 486 - 488. [Abstract] [PDF] |
||||
![]() |
I. Steiner, I. Wirguin, A. Morag, O. Abramsky, and P. R. Dyken Intraventricular Interferon Treatment for Subacute Sclerosing Panencephalitis J Child Neurol, January 1, 1989; 4(1): 20 - 24. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |